Chlamydia test – Heiki http://heiki.org/ Sun, 19 Jun 2022 12:25:30 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://heiki.org/wp-content/uploads/2021/04/cropped-icon-32x32.png Chlamydia test – Heiki http://heiki.org/ 32 32 Aeterna Zentaris will present at https://heiki.org/aeterna-zentaris-will-present-at/ Sun, 19 Jun 2022 12:25:30 +0000 https://heiki.org/aeterna-zentaris-will-present-at/

Live videowebcast eo on Wednesday June 15e at 12:30 p.m. ET

TORONTO, ONTARIO, June 09, 2022 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced Dr. Klaus Paulini, Chief from the management of Aeterna Zentaris will present at the JMP Securities Life Sciences Conference on Wednesday, June 15, 2022 at 12:30 p.m. ET to be held in New York, New York.

In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community registered to attend the conference. For more information, please visit the conference website.

A live video webcast of the presentation will be available on the Company’s website on the Events page of the Investors section of the Company’s website (zentaris.com). The webcast replay will be archived for 90 days after the event.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a specialty biopharmaceutical company that develops and markets a diverse portfolio of pharmaceutical and diagnostic products focused on areas of high unmet medical need. The Company’s lead product, macimorelin (Macrilen™; Ghryvelin®), is the first and only oral test approved by the US FDA and the European Commission indicated for the diagnosis of Adult Growth Hormone Deficiency (AGHD). The Company is building on the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of childhood growth hormone deficiency (CGHD), an area of ​​significant unmet need, in collaboration with Novo Nordisk.

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing preclinical pipeline to potentially address unmet medical needs in a number of indications, including neuromyelitis optica spectrum disorder ( NMOSD), Parkinson’s disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrig’s disease). Additionally, the Company is developing an oral prophylactic bacterial vaccine against SARS-CoV-2 (COVID-19) and Chlamydia trachomatis.

For more information, visit www.zentaris.com and connect with the company on Twitter, LinkedIn and Facebook.

Investor contacts:

jenene thomas
JTC-Team
T (US): +1 (833) 475-8247
E : [email protected]

Aeterna-Zentaris-Inc.png

]]>
Co-circulation of respiratory viruses during the Alpha outbreak of SARS-CoV-2 https://heiki.org/co-circulation-of-respiratory-viruses-during-the-alpha-outbreak-of-sars-cov-2/ Fri, 17 Jun 2022 02:47:00 +0000 https://heiki.org/co-circulation-of-respiratory-viruses-during-the-alpha-outbreak-of-sars-cov-2/

Scientists and policymakers have developed numerous strategies to reduce the emergence and spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the current coronavirus disease pandemic 2019 (COVID-19). For example, people have been asked to practice physical distancing, wear face masks, wash their hands frequently and dine next to each other indoors.

Brief report: Reduction and persistence of cocirculating respiratory viruses during the SARS-CoV-2 pandemic. Image Credit: Corona Borealis studio / Shutterstock

Background

The implementation of various measures formulated to prevent the spread of the SARS-CoV-2 virus has also contributed significantly to the reduction of influenza cases. According to the Centers for Disease Control and Prevention (CDC), only 0.2% of samples tested positive for influenza between September 28, 2020 and May 22, 2021. However, this was not the case during the three previous flu seasons, where the number of positive cases ranged between 26.2 and 30.3%.

The reduction in influenza cases indicates the effectiveness of the mitigation measures taken to limit SARS-CoV-2. Still, it’s unclear whether the control measures would also be effective against other respiratory viruses.

A new study

Recently, scientists assessed the influence of mitigation measures initially implemented to limit the transmission of COVID-19 on other respiratory viruses. This study is available as pre-proof in AJIC: American Journal of Infection Control.

In this study, researchers studied a panel of molecular respiratory pathogens on nasopharyngeal (NP) swabs obtained from symptomatic patients who opted for COVID-19 drive-thru testing centers at the respiratory diagnostic center (RDC) of the University of North Carolina Hospital between January 15 and April. 15, 2021. The authors considered all samples that were negative for SARS-CoV-2.

The researchers used a molecular respiratory pathogen panel, approved by the United States Food and Drug Administration (FDA), to screen for various respiratory pathogens, including endemic coronaviruses (HKU1, NL63, 229E, OC43), l adenovirus, rhinovirus/enterovirus, parainfluenza virus (PIV) 1, PIV2, PIV3, PIV4, metapneumovirus, influenza A (A/H1, A/H3, A/H1-2009), influenza B, respiratory syncytial virus (RSV ), Chlamydia pneumoniae, Bordetella pertussis, Bordetella parapertussis, and Mycoplasma pneumoniae.

Main findings

According to this study, 8.5% of 5,068 symptomatic outpatients were infected with SARS-CoV-2. The rest of the samples were available for further testing by the Molecular Respiratory Panel. The researchers revealed that the SARS-CoV-2 Alpha variant was circulating as the dominant strain during the study period.

Scientists reported that 18% of samples available for the molecular respiratory panel showed rhinovirus/enterovirus infection. Other viruses detected were RSV, PIV 2, PIV 3, metapneumovirus, adenovirus and endemic coronaviruses (229E, NL63, OC43). Interestingly, the researchers observed that bacterial targets and influenza viruses were not detected in any of the samples tested.

The current study strongly suggests that infection with certain respiratory viruses, such as influenza, could be prevented by implementing preventive measures (eg, social behavior changes).

Implications of the study

The authors stated that the reduction in influenza virus transmission occurred due to several factors, and one of the key factors was the implementation of mitigation strategies to inhibit the transmission of SARS- CoV-2. The presence of other viruses, such as rhinovirus/enterovirus, indicates that their mode of transmission differs from SARS-CoV-2.

During the COVID-19 pandemic, scientists and policymakers have been particularly focused on formulating mitigation measures based on preventing the spread of respiratory aerosols and droplets generated by patients infected with SARS-CoV-2 . Less attention has been paid to the possibility of transmission of the virus via contaminated surfaces.

Previous studies have indicated that enveloped viruses (eg, SARS-CoV-2 and influenza) are easily inactivated by frequent hand washing and use of disinfectants, while non-enveloped viruses (eg, rhinovirus /enterovirus) could not be managed through these measures.

This study strongly suggests that non-pharmaceutical prevention measures have significantly reduced the spread of the majority of respiratory viruses compared to previous seasons. However, the increased use of surface disinfectants, especially in hospitals and nursing homes, was strongly recommended.

]]>
What does blood in semen mean? https://heiki.org/what-does-blood-in-semen-mean/ Wed, 15 Jun 2022 04:00:00 +0000 https://heiki.org/what-does-blood-in-semen-mean/

Introduction
Infection or inflammation
Duct Blockage
Tumors
Vascular problems
Diseases
Organ injury
Management of hematospermia
Do prostate diseases cause hematospermia?
References


Semen is a fluid made up of sperm as well as fluids from the prostate and other glands. The resulting seminal fluid or ejaculate passes through several channels on its way to the urethra.

First come the seminal vesicles, accessory sex organs in men, located just above the prostate and behind the bladder, one on each side. These flat elongated organs produce and store seminal fluid. Their secretion flows into the ampullae of the vasa.

Sperm is transported from the epididymis of the testis via the vas deferens to the vasal ampullae, two tubes passing between the seminal vesicles. The prostate is a gland located at the base of the bladder and wrapped around the neck of the bladder. The ejaculatory duct is formed in the prostate by the junction of the vasal ampullae and the seminal vesicles. It crosses the prostate to enter the urethra.

The presence of blood in the seminal fluid is often a shock. It has been reported as early as the time of Hippocrates. About 15% of cases still occur without an obvious cause. The rest can be attributed to several causes.

Most patients with blood in semen are under the age of 40 and have self-limited bleeding episodes. Older patients are more likely to have recurrent bleeding episodes.

Image Credit: KateStudio/Shutterstock.com

Infection or inflammation

The most common causes include cysts in the seminal vesicles or ejaculatory duct or bleeding into the duct, accounting for more than two-thirds of patients with hematospermia in one study.

All organs involved in the production and passage of seminal fluid can become inflamed, including the seminal vesicles, vas deferens, testicles, epididymis, prostate, or urethra. Irritation of the gland, injury, the presence of calcified foci or stones in the tubular organs or infections – bacterial, viral, fungal or parasitic – can cause inflammation. Sexually transmitted diseases (STDs), including gonorrhea, herpes, or chlamydia, can also cause hematospermia.

Duct Blockage

Any blockage of the ejaculatory duct or cysts formed inside the prostate or seminal vesicles can cause blood to appear in the semen. This is due to the dilation of blood vessels near the blocked channel, causing the vessel to rupture.

Urethritis is a known cause of hematospermia, more commonly in younger men. Cysts and other benign growths, urethral strictures or warts may be responsible for some cases.

Tumors

The growth of tumors, including benign polyps or cancers of the testicles, prostate, epididymis, or seminal vesicles, can cause hematospermia. Yet the risk of cancer in men with this symptom remains low, at 3.5%. Cancer is almost never the cause in men under 40 and is rare even in older men.

Prostate tumor

Image Credit: Kateryna Kon/Shutterstock.com

Vascular problems

Sometimes the blood vessels supplying or passing through these organs can be abnormally dilated, like telangiectasias or varicose veins, causing blood to leak into the semen.

Diseases

Conditions such as hypertension, hemophilia, or chronic liver disease can trigger bleeding in semen. Along with hypertension, severe and uncontrolled increases in blood pressure, elevated serum creatinine, severe proteinuria, and kidney blood vessel disease are risk factors for hematospermia. Tuberculosis of the vas deferens could also trigger hematospermia, as could hyperuricemia.

Organ injury

Hematospermia is mostly due to medical procedures, including prostate biopsy (up to 84% in some studies), radiation therapy, or prostate surgery. Pelvic fractures, damage to the perineal region or testicles, and prolonged abstinence from sexual intercourse are less common causes.

Management of hematospermia

The doctor should look for the presence of blood in the semen. A careful history, examination of the area, and relevant blood and urine tests will help distinguish between different causes. A check may be ordered to rule out prostate cancer, called a prostate-specific antigen (PSA) test.

In most cases, the hematospermia disappears within two months, and if not, other tests may be necessary. Chronic bleeding or recurrent episodes should trigger further evaluation.

Ultrasound may be helpful if blood persists in the prostate. Treatment will depend on the cause, of course, but a policy of watchful waiting can be adopted if none is found.

hematospermia

Image Credit: Najeeb Designz/Shutterstock.com

Do prostate diseases cause hematospermia?

Obstruction of the urethra by an enlarged prostate, as in benign prostatic hyperplasia, can also cause hematospermia.

Prostate biopsy is thought to be most often related to hematospermia, although it is usually self-limited. Prostate cancer is another possible cause, but it is still thought to be rare. Some studies have reported a risk of around 14% with this symptom. Yet others have shown it to be present in 6% of men over 40 who have elevated PSA or abnormal prostate exam results.

Thus, those who have crossed 40 years might find it helpful to screen for prostate cancer if persistent hematospermia presents at any time that is not explained by other causes. These include prostatitis, including bacterial prostatitis; cysts of seminal vesicles or other accessory glands; stones in the prostate; or prostatic cysts.

Red flags indicating the need for further investigation aside from age include a family history of prostate cancer, African descent, or features of malignancy such as loss of appetite, bone pain and weight loss.

People under this age who have one or very few episodes of hematospermia and are at low risk for prostate cancer should be screened for other common diseases of the genitourinary system and managed Consequently.

References:

Further reading

]]>
Active duty US soldier stationed in Germany is the first military case of monkeypox https://heiki.org/active-duty-us-soldier-stationed-in-germany-is-the-first-military-case-of-monkeypox/ Sat, 11 Jun 2022 14:19:05 +0000 https://heiki.org/active-duty-us-soldier-stationed-in-germany-is-the-first-military-case-of-monkeypox/

An active duty US soldier based in Germany has been identified as the Army’s first known case of monkeypox.

The soldier – who has not been named – tested positive for the tropical disease at the base in Stuttgart, in the southwestern region of the country where around 23,000 troops are stationed, CNN reported.

Military officials have now quarantined the individual in their quarters until the symptoms resolve.

Revealing the case on Friday, Navy Captain William Speaks said: ‘We can confirm that a member of the Stuttgart military community guard recently tested positive for monkeypox.

“The individual was seen and treated at the army health clinic in Stuttgart and is currently in isolation.”

It comes as the number of monkeypox cases in America rose to 49 on Friday, with Rhode Island becoming the fifteenth state to report a case of the disease.

A US soldier based at US Army Garrison Base Stuttgart in Germany (pictured) has contracted monkeypox, the first known case of the disease in the military.

The American is currently quarantined inside the army health clinic in Stuttgart (pictured)

The American is currently quarantined inside the army health clinic in Stuttgart (pictured)

A total of 49 monkeypox cases have now been recorded in 15 states across America and Washington DC.  The Centers for <a class=Disease Control and Prevention says most cases are in people who recently returned from overseas.” class=”blkBorder img-share” style=”max-width:100%” />

A total of 49 monkeypox cases have now been recorded in 15 states across America and Washington DC. The Centers for Disease Control and Prevention says most cases are in people who recently returned from overseas.

At the base in Stuttgart, German authorities have been notified of the case and contact tracing is ongoing.

Speaks added: “Public health officials have determined that the risk to the general population is very low.

“The case in Stuttgart is that of the West African strain, which is generally mild and has limited human-to-human transmission.”

Medical literature indicates that people infected with monkeypox experience flu-like symptoms within the first 21 days of infection with the virus, followed by a rash that appears on the face before spreading to the rest of the body.

But this is rarely seen in the current outbreak, with patients instead seeing rashes appear on the genital areas before experiencing flu-like symptoms.

Germany has detected 165 cases of monkeypox so far, according to local officials, as the disease has spread to dozens of countries in recent months.

In a Friday briefing, Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention (CDC), said monkeypox is transmitted through physical contact with symptomatic patients and by touching their clothing and bedding.

But attempting to determine whether face masks are necessary to avoid catching the rash-causing virus, the epidemiologist explained that the rash-causing virus would not “linger in the air” like Covid.

“The disease is not spread through casual conversations, passing other people in a grocery store, or touching things like doorknobs,” she said. “All of the cases we’ve seen so far in this outbreak have been linked to direct contact.”

During the conference, health officials also called on Americans with any sexually transmitted infection — including syphilis, gonorrhea and chlamydia — to get tested for monkeypox.

Dr Rochelle Walensky, who heads the Centers for Disease Control and Prevention, said monkeypox can only spread through the air through prolonged face-to-face contact.

Dr Jennifer McQuiston, who is leading the agency's response, said most of the cases were in people who had recently traveled

Dr Rochelle Walensky (left), who heads the Centers for Disease Control and Prevention, said monkeypox can only spread through the air through prolonged face-to-face contact. Dr Jennifer McQuiston (right), who is leading the agency’s response, said most of the cases were in people who had recently traveled

Authorities urge gay and bisexual men to be aware of new lesions, rashes or scabs and to get in touch with a sexual health clinic

Authorities urge gay and bisexual men to be aware of new lesions, rashes or scabs and to get in touch with a sexual health clinic

They warned that many patients were suffering from rashes and sores on their genitals and anus that looked like STIs. Several cases of co-infection with monkeypox and a sexually transmitted disease have also been recorded.

Health officials also revealed they had distributed more than 1,400 vaccines against the virus to states from their stockpile of more than a million doses. Another 300,000 doses are expected to arrive in the coming weeks.

But some experts have raised concerns that the country may not have enough bites because if the outbreak becomes widespread there may not be enough to bite the whole country.

America recorded eight cases of the virus between Wednesday afternoon and Friday morning, as the scale of the outbreak across the country continues to grow.

About three in four cases are currently linked to international travel, including to Europe, while others are linked to someone who had close contact with a known case.

But there are “several” patients in multiple states who have tested positive despite not having traveled recently or been in contact with a known case.

Dr Jennifer McQuiston, who is leading the CDC’s response to the outbreak, said it’s likely they picked up the infection from someone who had recently traveled, but that first case hasn’t yet been spotted.

She added: ‘I can tell you right now we don’t have an area that seems to have an urban outbreak. There is not a single area where there seems to be a lot of community transmission.

“But that could change. We need to make sure our tests are increasing and ready to catch this when it happens.

The infection often starts as small bumps that crust over and are contagious

The infection often starts as small bumps that crust over and are contagious

America has performed just 300 tests for orthopox viruses – the family that includes monkeypox – since the outbreak began, despite more than 69 labs available to take thousands of swabs a day.

Health officials are asking states to send more samples to labs, but states complain that the process is “too complicated” because after going to those labs, the swabs must be sent to the CDC for confirmation.

New York reported two new cases of monkeypox yesterday, while Illinois and Florida reported one and Rhode Island revealed its first infection which they say may be “linked to a trip to Massachusetts.”

Hawaii also reported its third case in a week in a person who had not traveled recently, prompting authorities to warn that the tropical disease could spread undetected in the archipelago.

]]>
Reactivating an infection is dangerous https://heiki.org/reactivating-an-infection-is-dangerous/ Tue, 07 Jun 2022 20:38:00 +0000 https://heiki.org/reactivating-an-infection-is-dangerous/

The performance of the immune system varies throughout a person’s life. During infancy and early childhood, when the immune system is immature, people are at risk of infection with a persistent microbe such as cytomegalovirus, chlamydia, Lyme disease organism, or a virus like herpes.

In fact, by the age of 3, 100% of young children test positive for another type of latent herpes virus called HHV-6. This virus may also play a role in Alzheimer’s disease.

Among children ages 6 to 16, those who test positive for HSV-1 infection have been shown to have lower reading and spatial reasoning scores. HSV-1 and cytomegalovirus infections in middle-aged adults (20-59 years) are associated with impaired learning and memory.

As we reach old age, the immune system also ages and we again become susceptible not only to new infections, but also to the reactivation of existing latent infections – dormant viruses, bacteria and spirochetes.

These latent infections can have adverse effects on cognition throughout life. The more a person has a reactivation of these dormant viruses, the greater their risk of not only developing Alzheimer’s dementia, but also social problems related to thinking, educational level and social mobility.

These viral reactivations are directly dependent on the health of the immune system. What we are seeing now is that more and more people are suffering from immune deficiency caused by factors such as:

• A poor diet

• Diabetes

• Chronic stress

• Exposure to industrial chemicals

• Exposure to pesticides, herbicides and fungicides

• Excessive vaccinations

People are particularly vulnerable to these factors during infancy and old age. Of those factors, I think the worst are vaccines, because the majority of vaccines are known to switch the immune system into what’s called a Th2 mode, which suppresses immunity. The fact that children over 40 receive vaccinations before entering school can be a major cause of chronic infections.

Once a persistent virus has established itself, it can also suppress immunity. The measles virus, for example, is a major immune suppressor, and the measles vaccine uses a live virus.

Studies have shown that in a high percentage of people, the measles virus persists in the brain for life.

© 2022 Newsmax Health. All rights reserved.

]]>
Global Chlamydia Infection Testing Market Size 2022 Booming By Share, Growth Size, Scope, Key Segments & Forecast To 2029 – Industrial Computing https://heiki.org/global-chlamydia-infection-testing-market-size-2022-booming-by-share-growth-size-scope-key-segments-forecast-to-2029-industrial-computing/ Mon, 06 Jun 2022 01:46:19 +0000 https://heiki.org/global-chlamydia-infection-testing-market-size-2022-booming-by-share-growth-size-scope-key-segments-forecast-to-2029-industrial-computing/

New Jersey, United States – The Global Chlamydia Infection Testing Market report examines the current status of the global Chlamydia Infection Testing market and industry in detail. All necessary data or information such as market terminologies, concepts, segmentation, key players and other critical information is included in the study. Company profiles, executive descriptions and other relevant data are also featured.

To make the Global Chlamydia Infection Testing Market report more informative and valuable for businesses, the experts at VM Reports have provided a range of information. The research includes SWOT analysis, which helps companies understand their strengths, weaknesses, opportunities and threats in a challenging market.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=472767

(Use company email id to get higher priority)

A section is also devoted to the major players and their ambitions, such as acquisitions, mergers, etc. Multiple perspectives, personal interviews, and surveys were used to compile the data for the global Chlamydia Infection Testing market research. The professionals at VM Reports have prepared a research report on Global Chlamydia Infection Testing Market which is packed with clarity, precision and insightful data. The information contained in the report is accurate and reliable, without redundancies or omissions.

Top Key Players in Chlamydia Infection Testing Market Research Report:

Abbott, ADI/American Diagnostica, Agilent Technologies, Chrono-Log, Corgenix, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, International Technidyne/Nexus DX, Kreatech/Leica, Polymedco, Qiagen, Roche, SDIX, Sequenom , Siemens

Data is collected by VM Reports specialists using a combination of qualitative and quantitative data approaches. Both primary and secondary data techniques have been used to create an engaging report that the organization and clients can use whenever they need. The study will also examine the key global alliances, initiatives, and partnerships that are expected to have a global impact on the market dynamics shortly.

Key Segments Covered in Chlamydia Infection Testing Market – Industry Analysis by Types, Applications and Regions:

Chlamydia Infection Testing Market – Type Outlook (Revenue, USD Million, 2017-2029)

• Nucleic Acid Amplification Tests (NAAT)
• Direct fluorescence tests

Chlamydia Infection Testing Market – Application Outlook (Revenue, USD Million, 2017-2029)

• Hospitals
• Commercial/private laboratories
• Doctors’ offices
Public health laboratories

For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/chlamydia-infection-test-market-size-and-forecast/

Scope of the Chlamydia Infection Testing Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Chlamydia Infection Testing Market Regional Analysis:

The Chlamydia Infection Testing market research report details current market trends, development outline, and several research methodologies. It illustrates the key factors that directly manipulate the market, for example, production strategies, development platforms, and product portfolio. According to our researchers, even minor changes in product profiles could lead to huge disruptions in the factors mentioned above.

➛ North America (United States, Canada and Mexico)
➛ Europe (Germany, France, United Kingdom, Russia and Italy)
➛ Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
➛ South America (Brazil, Argentina, Colombia, etc.)
➛ Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

What insights does the Chlamydia Infection Testing market report provide readers?

➜ Chlamydia Infection Test fragmentation based on product type, end use and region
➜ Comprehensive assessment of upstream raw materials, downstream demand and current market landscape
➜ Collaborations, R&D projects, acquisitions and product launches of each Chlamydia Infection Test player
➜ Various regulations imposed by governments on the consumption of Chlamydia Infection Test in detail
➜ Impact of modern technologies, such as big data and analytics, artificial intelligence and social media platforms on Chlamydia infection testing

Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=472767

Visualize Chlamydia Infection Testing Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Chlamydia Infection Testing Market Using VMI@ https://www.verifiedmarketresearch.com/vmintelligence/

Most Popular Reports

Global Veno-Venous Extracorporeal Life Support (VV ECLS) Market Size and Forecast

Global amniotic hook market size and forecast

Global Powered Surgical Tools Market Size and Forecast

Global HIV Testing Kits Market Size and Forecast

Global AIDS Testing Kits Market Size and Forecast

Global Infectious Disease Testing Kits Market Size and Forecast

Global Hepatitis C Virus (HCV) Testing Market Size and Forecast

Global Respiratory Disease Diagnostic Testing Market Size and Forecast

Global Chlamydia Diagnostic Tests Market Size and Forecast

Global Chlamydia Infection Testing Market Size and Forecast

About Us: Verified Market Reports

Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

Contact us:

Mr. Edwyne Fernandes

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

E-mail: [email protected]

Website: – https://www.verifiedmarketreports.com/

]]>
Health tips: Here’s how every woman should take care of her sexual health | Health https://heiki.org/health-tips-heres-how-every-woman-should-take-care-of-her-sexual-health-health/ Sat, 04 Jun 2022 07:10:07 +0000 https://heiki.org/health-tips-heres-how-every-woman-should-take-care-of-her-sexual-health-health/

Women’s sexual health focuses on safer sex practices, regular screening for sexually transmitted infections (STIs), choice of vaccines and medications, appropriate use of contraception, and obtaining medical treatment for reproductive health issues and, according to the World Health Organization (WHO), sexual health includes not only individuals, couples and families, but also entire communities and cultures. It is important for women to know about the different contraceptive options available to them, as this can help them better manage their family planning decisions related to the timing and size of their family.

Women should feel free and interested in discussing their options with their doctor. Stating that women should know how to protect themselves and their partners from the risk of contracting a sexually transmitted disease, Dr Kiran Coelho, consultant in gynecology and obstetrics at PD Hinduja Hospital & Medical Research Center in Khar, said in an interview with HT Lifestyle, “Adequate protection during sexual activity can help prevent transmission of STDs. Women should be aware of simple contraceptive measures like condoms (barrier method) to prevent STDs.

She advised, “Every woman should be immunized with HPV vaccines like Gardasil, Cervarix, etc., which not only protects them from warts caused by the human papilloma virus, but also from cervical cancer. These vaccines are most effective when taken before the age of sexual activity. Screening can help reduce the risk of contracting an STD. Regular STD testing can help reduce the long-term effects of an infection. Untreated, bacterial STDs such as gonorrhea and chlamydia can have serious negative effects on your health, including infertility. Screening can help prevent these complications.

Since many women think menstruation is supposed to be painful, they may not discuss their discomfort with their doctor. However, Dr Kiran Coelho warned: “Severe pain during your period can be a sign of an underlying gynecological or gastrointestinal health problem and should seek prompt treatment. It is important that women do not take lightly the symptoms related to their sex life like low libido, pain during intercourse, orgasm problems, etc.

According to Dr. Kshitiz Murdia, CEO and co-founder of Indira IVF, it has been observed that the awareness of caring for and maintaining one’s sexual health is limited in India, especially when it comes to women. He said: “This can be attributed to the way topics under the umbrella of youth sex education and the like are considered taboo and its discussion stifled. This lack of information can lead women not to recognize the symptoms of sexually transmitted infections, to contract infections, to have unwanted pregnancies, to be unaware of diseases of the reproductive system and its medical treatment.

He listed a few points to understand the same:

1. Sexually Transmitted Infections (STIs) – STIs are infections of the reproductive organs caused by sexual acts. These can be spread with the exchange of sexual fluids, including penetration, oral contact, and anal sex. Additionally, in mothers living with STIs, it can be transmitted from mother to child during pregnancy as well as during breastfeeding. It therefore becomes essential for women to monitor STIs by regularly visiting their gynecologist, not only to protect themselves but also to protect their partner and their future children. An effective way to prevent STIs is to have safer sex by using condoms and dental dams while engaging in sexual activity.

2. Vaccines as a preventive measure – STIs can be caused by different microorganisms, including bacteria and viruses. Currently, there are vaccines against STIs caused by viruses, including human papillomavirus (HPV) and hepatitis B. HPV is known to cause cervical cancer. These vaccines therefore also contribute to prevention in women. HPV and hepatitis B vaccines are optimal when taken before women become sexually active.

3. Safe Sex Practices – Safe practices adopted during sex help in two ways – by keeping STIs at bay and avoiding unwanted practices. Using barriers such as condoms and internal condoms during intercourse and oral sex is a way to stop the exchange of sexual fluids including semen which can cause pregnancy if fused with an egg. Dental dams and nitrile gloves are other barriers used during oral sex and other sexual contacts to prevent STIs. In addition, it is essential to follow a hygiene routine before and after sexual intercourse. Keeping sexual partners to a minimum is an ideal case. Between two partners, it is imperative that STI screening is performed to detect any infection present; this can help contain the spread of infections, should they occur. Moreover, undetected STIs can spread their impact to different parts of the body causing complications and leading to infertility.

4. See a medical professional regularly – Regular visits to the doctor’s clinic and highlighting any sexual and reproductive health issues can help bring a number of issues to light, if any. For example, an irregular or painful menstrual cycle is a clear symptom of an underlying condition – such as polycystic ovary syndrome (PCOS) or endometriosis – in the reproductive organs or hormones. Timely detection and treatment can stop complications.

]]>
Know the players using the latest advancements to dominate the industry, . – mbu timeline https://heiki.org/know-the-players-using-the-latest-advancements-to-dominate-the-industry-mbu-timeline/ Thu, 02 Jun 2022 17:14:36 +0000 https://heiki.org/know-the-players-using-the-latest-advancements-to-dominate-the-industry-mbu-timeline/

Decisive Market InsightsStudy Report Added Latest World Report Native Bacterial Antigens Market which has a comprehensive review of this industry regarding the driving forces influencing the market size. Comprising current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of the global market in tandem with its competitive terrain.

Please click on the link below if you intend to make a direct purchase @:-https://www.decisivemarketsinsights.com/native-bacterial-antigens-market/12701885/buy-now

Native Bacterial Antigens Market Segmentation
By type:
Chlamydia trachomatis, Native Chlamydia trachomatis, Clostridium difficile Toxoid A, Clostridium difficile Toxoid B, Native lipoteichoic acid, Others
Per application:
ELISA, immunoassay, SDS-PAGE, hemagglutination, agglutination test
By key players: Microbix Biosystems SERION Immunologics Bio-Rad Laboratories Enzo Life Sciences Jena Bioscience GmbH QED Bioscience Ross Southern Laboratories# AROTEC Diagnostics The Native Antigen Company Creative Diagnostics

The research report on the global market has been methodically compiled to provide a detailed account of the factors influencing the dynamics of the industry in the coming years. The research literature classifies this field into different segments and studies them individually to unveil the most profitable revenue prospects.

For Sample Copy of Report Visit @ https://www.decisivemarketsinsights.com/native-bacterial-antigens-market/12701885/request-sample

As quoted by credible experts, the world Native Bacterial Antigens Market is expected to amass significant gains, posting a compound annual growth rate of XX% over the study period 2021-2026. Speaking of the latest developments, the unexpected outbreak of the Covid-19 pandemic has severely affected most, if not all, sectors of the global economy. Businesses face a plethora of challenges, including resource scarcity, changes in the supply and demand chain, and declining revenues. In this regard, our holistic analysis of this changing landscape helps design effective business plans that can ensure an upward growth trajectory in the years to come.
Key Highlights of the Global Market Report:

• The estimated compound annual growth rate of the market and submarkets.
• Implications of the Covid-19 pandemic on the compensation scope.
• Prevailing industry trends.
• Strengths and weaknesses of direct and indirect sales channels.
• Main traders, distributors and sellers.
• Emerging market trends and potential new market avenues
• Governing body regulations and policies on use of merchandise
• In-depth analysis of market segments
• Historical, current and future estimated prices and market size
• Recent developments and innovations in the market
• Competitive landscape
• Entry-level and winning strategies that can help companies increase their market share.

In order to make a pre-order request, please click on the link below:-https://www.decisivemarketsinsights.com/native-bacterial-antigens-market/12701885/pre-order-enquiry

Decisive Markets Insights’ team of in-house analysts have been monitoring the market for a few years and have conducted interviews with industry experts to encourage a better understanding of the Native Bacterial Antigens Market future scenario. This report gives an in-depth evaluation of the fragments and sub-parts of this global market. It gives a broad perspective on each shard’s utility, market valuation, and development chance along with the expected CAGR, including an assortment of subparts of each section throughout the gauge period . This research report is ready with the help of an intensive robust methodology that incorporates Porter’s five forces analysis, predictive analytics and real-time analytics curation.

Please contact us and our expert will get back to you within 30 minutes:
Critical market insights
Sunil Kumar
Head of sales

E-mail – [email protected]
Website – https://www.decisivemarketsinsights.com
United States +18317045538
UK +441256636046
Address: – 26 Broadway, Suite 934, New York, 10004

Social connections:
Twitter-https://twitter.com/decisivemarket

Linkedin-https://www.linkedin.com/company/decisive-markets-insights

]]>
Updated Analysis of Sexually Transmitted Diseases (STD) Diagnostics Market Future Trends, Scope, Key Players from 2016 to 2028 https://heiki.org/updated-analysis-of-sexually-transmitted-diseases-std-diagnostics-market-future-trends-scope-key-players-from-2016-to-2028/ Sun, 29 May 2022 16:44:17 +0000 https://heiki.org/updated-analysis-of-sexually-transmitted-diseases-std-diagnostics-market-future-trends-scope-key-players-from-2016-to-2028/

The Global”Sexually Transmitted Diseases (STD) Diagnostics Market“The report provides insight into the global industry, including valuable facts and figures. This research study explores the global market in detail such as industry chain structures, raw material suppliers, and manufacturing. The Sexually Transmitted Diseases (STD) Diagnostics Sales Market examines the major segments of the market scale. This smart study provides historical data as well as a forecast from 2022 to 2028.

The entire value chain and the critical downstream and upstream elements are examined in this report. This market report covers technical data, manufacturing facility analysis, and raw material supply analysis for Sexually Transmitted Disease (STD) Diagnostics industry and also explains which product has the highest penetration high, its profit margins and its market share.

Main Drivers and Obstacles:

High-impacting factors and rendering drivers have been studied in the Sexually Transmitted Diseases (STD) Diagnostics market report to help readers understand the overall development. Additionally, the report contains restrictions and challenges that may hinder players. This will help users pay attention and make informed trading decisions. The specialists also looked at the next business prospects.

In its latest report, ReportsGlobe offers a comprehensive overview of the Sexually Transmitted Diseases (STD) Diagnostics Market with a focus on keyword dynamics including driving forces, restraints, opportunities, trends and insights. detailed information about the structure of the Sexually Transmitted Diseases (STD) Diagnostics Market. Sales of the Sexually Transmitted Diseases (STD) Diagnostics Market in the global market will increase as the business and advanced technologies increase. With the covid-19 epidemic, companies have become very dependent on digital platforms to survive.

Global Sexually Transmitted Diseases (STD) Diagnostics Market Segmentation:

Sexually Transmitted Disease (STD) Diagnostics Market, By Application (2016-2027)

  • Government organizations
  • Hospitals
  • Diagnostic clinics

Sexually Transmitted Disease (STD) Diagnostics Market, By Product (2016-2027)

  • Chlamydia test
  • Syphilis screening
  • Gonorrhea test
  • Herpes simplex virus test
  • Screening for human papillomavirus
  • Human immunodeficiency virus screening

Key Players operating in the Sexually Transmitted Diseases (STD) Diagnostics Market:

  • Abbott
  • rock
  • Thermo Fisher Scientific
  • Aposcience
  • BCR diagnosis
  • Medical comics
  • Biocartis
  • BioMerieux
  • Bio-Rad
  • Cepheid
  • Danaher
  • DiaSorin
  • Quidel
  • GenMark Diagnosis
  • Hological
  • OraSure Technologies
  • Qualigen

Sexually Transmitted Disease (STD) Diagnostics Market Segment Analysis

The market study explores new data in the Sexually Transmitted Diseases (STD) Diagnostics Market report. It examines the market size in terms of the value of each segment, as well as how market dynamics are likely to change over time. The report then divides this information into types and proposed applications, with a geographical breakdown (North America, Asia, Europe, and Rest of the World). In addition, the report examines the structure of the industry, offers estimates of growth, forecast period, revenue value, and volume in industrial applications, and sheds light on industry competition.

Scope of the Sexually Transmitted Diseases (STD) Diagnostics Market Report

ATTRIBUTES

The description

ESTIMATED YEAR

2022

YEAR OF REFERENCE

2021

FORECAST YEAR

2022 to 2028

HISTORICAL YEAR

2020

SECTORS COVERED

Types, applications, end users, and more.

REPORT COVER

Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

BY REGION

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Sexually Transmitted Diseases (STD) Diagnostics Market Regional Analysis:

The Sexually Transmitted Diseases (STD) Diagnosis Market research report details current market trends, development outline, and several research methodologies. It illustrates the key factors that directly manipulate the market, for example, production strategies, development platforms, and product portfolio. According to our researchers, even minor changes in product profiles could lead to huge disruptions in the factors mentioned above.

  • North America includes the United States, Canada and Mexico
  • Europe includes Germany, France, UK, Italy, Spain
  • South America includes Colombia, Argentina, Nigeria and Chile
  • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

Aims and objectives of the Sexually Transmitted Diseases (STD) Diagnosis Market Research

  • Understanding the opportunities and advancements in Sexually Transmitted Diseases (STD) Diagnostics determines the market strengths, along with the key regions and countries involved in the market growth.
  • Study the various segments of the Sexually Transmitted Diseases (STDs) Diagnostics market and the dynamics of the Sexually Transmitted Diseases (STDs) Diagnostics in the market.
  • Categorize the Sexually Transmitted Diseases (STD) Diagnostics segments with increasing growth potential and assess the market for the futuristic segment.
  • To analyze the most important trends related to the various segments which help to decipher and convince the Sexually Transmitted Diseases (STD) Diagnostics market.
  • Check region-specific growth and development in the Sexually Transmitted Diseases (STD) Diagnostics Market.
  • Understand the major players in the Sexually Transmitted Diseases (STDs) Diagnostics Market and the competitive image value of the Sexually Transmitted Diseases (STDs) Diagnostics Market Leaders.
  • To study the key plans, initiatives, and strategies for the development of the Sexually Transmitted Diseases (STD) Diagnostics Market.

The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Sexually transmitted disease (STD) diagnosis historical distribution data from 2016 to 2021 and forecast for 2022-2028.

Global Sexually Transmitted Disease (STD) Diagnostics Market Research Report 2022-2028

Chapter 1 Sexually Transmitted Diseases (STD) Diagnostics Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 – Global Sexually Transmitted Diseases (STD) Diagnostics Market Forecast

How Reports Globe is different from other market research providers:

The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

Contact us:

Mr. Mark Williams

Account Manager

WE: +1-970-672-0390

E-mail: [email protected]

Website: Reportsglobe.com

]]>
Europe STD Diagnostic Testing Market Key Analytics, Industry Chain, Geographic Scope, Forecast by 2028 – ManufactureLink https://heiki.org/europe-std-diagnostic-testing-market-key-analytics-industry-chain-geographic-scope-forecast-by-2028-manufacturelink/ Fri, 27 May 2022 15:46:45 +0000 https://heiki.org/europe-std-diagnostic-testing-market-key-analytics-industry-chain-geographic-scope-forecast-by-2028-manufacturelink/

Details Overview of STD Diagnostic Tests Market Overview 2022

This section discusses various aspects of the STD Diagnostic Testing industry including its size, trends, revenue forecast and latest update: It brought about several changes, this report also covers situation impact current situation of COVID-19. Request sample now

Sexually transmitted diseases (STDs) are mainly spread through person-to-person sexual contact. Various test technologies used for the identification and analysis of contracted STDs include the definition of “STD diagnostic test”. The STD market research diagnostic tests literature also presents exclusive sections for the assessment and conclusion of the revenue outlook for each market segment. The STD Diagnostic Testing Market report concludes with a detailed assessment of this industry, highlighting the growth drivers and lucrative prospects likely to affect the Global STD Diagnostic Testing Market during the period. forecast.

The STD Diagnostic Tests Market report provides an in-depth analysis of the current state of the industry including its technology trends, competitive landscape, key players, revenue forecast at global, regional and country levels . It also provides comprehensive coverage of key industry drivers, restraints and their impact on market growth over the forecast period. For research purposes, the report has segmented the global STD diagnostic tests market on the basis of type, technology and region.

Get Sample PDF Copy of STD Diagnostic Testing Market @ https://www.reportsinsights.com/sample/594762

Leading competitors in the Global STD Diagnostic Testing Market are:
Roche, Alere, Becton Dickinson, BioMérieux, Danaher, Hologic

The STD Diagnostic Tests market research literature also presents exclusive sections for the assessment and conclusion of the revenue outlook for each market segment. The report concludes with a detailed assessment of this industry, highlighting the growth drivers and lucrative prospects that are likely to impact the Global STD Diagnostic Testing Market over the forecast period.

This section discusses various aspects of this industry, including its size, trends, and revenue forecasts. The STD diagnostic tests market is segmented by product type, end-user industry and geography.

The main types of products covered are:
Chlamydia test

Gonorrhea test

P&S Syphilis Testing

HPV test

HSV test

HIV testing

Chancroid test

The application coverage in the market is:
Hospitals

Clinics

STD Diagnostic Testing Market Scope:

ATTRIBUTES DETAILS
YEAR OF REFERENCE 2021
FORECAST YEAR 2022-2028
UNITY Value (million USD/billion)
CAGR Yes (%)
SECTORS COVERED Key Players, Types, Applications, End Users etc.
REPORT COVER Total Revenue Forecast, Company Ranking & Market Share, Regional Competitive Landscape, Growth Factors, Emerging Trends, Business Strategies, etc.
REGIONAL ANALYSIS North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

To request an investigation of this report: https://www.reportsinsights.com/enquiry/594762

Regional STD Diagnostic Testing Market (Regional Production, Demand and Forecast by Regions):-
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Ecuador, Chile)
Asia-Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and more.

Main points covered in the table of contents:

  • STD Diagnostic Test Market Overview
  • Market competition by manufacturers
  • Picture of STD Diagnostic Tests Production and Global STD Diagnostic Tests Market: Classification
  • Global Regional STD Diagnostic Test Market Demand
  • Market breakdown and data triangulation approach
  • Company, region, product type, sales channel – trends
  • STD Diagnostic Tests Market Dynamics: Constraints, Opportunities, Industry Value Chain, Porter’s Analysis and others
  • Impact of Covid-19 on global demand for STD diagnostic tests
  • Market analysis forecast by segments
  • Competitive analysis
  • Market Research Findings and Conclusion The research report studies the past, present and future performance of the global market. The report further analyzes the current competitive scenario, prevalent business models, and likely advances of offerings by prominent players in the coming years.

Key Questions Answered by the Report

  • What are the leading eyeliner brands in the STD diagnostic test market?
  • What are the main strategies that players should adopt in the coming years?
  • What are the trends in this STD Diagnostic Test market?
  • How will the competitive landscape change in the future?
  • What are the challenges of this STD diagnostic tests market?
  • What are the market opportunities and market overview of the STD Diagnostic Testing market?
  • What are the key drivers and challenges in the Global STD Diagnostic Testing Market?
  • How is the global STD diagnostic testing market segmented by product type?
  • What will be the growth rate of the global STD diagnostic tests market 2022 for the forecast period 2022 to 2028?
  • How big will the market be during this estimated period?
  • What opportunities can business owners count on to generate more profits and stay competitive during the estimated time?
  • Potential and niche segments/regions showing promising growth
  • A neutral perspective on the performance of the global STD diagnostic tests market

Access full report description, table of contents, table of figure, graph, etc. @ https://www.reportsinsights.com/industry-forecast/diagnostic-testing-of-stds-markets-growth-trends-594762

About Us:

Reports Insights is the research industry leader providing contextual, data-centric research services to clients worldwide. The firm assists its clients in developing business policies and achieving sustainable growth in their respective market area. The industry provides consulting services, syndicated research reports, and custom research reports.

Contact us:

E-mail: [email protected]

Sales: [email protected]

]]>